During the next ten years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.
The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostics market during the next ten years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Sales and Market Share Analysis
Sales and market share estimates for leading
suppliers of transfusion diagnostic testing reagents
and instruments, by country and individual
Annual placements and installed base of
major automated and semi-automated
analyzers, by supplier and model.
Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.
- Test volume and sales forecasts for over 40
transfusion diagnostic tests, including NAT,
by country and market segment:
- Blood Centers
- Plasma Fractionation Facilities
- Commercial/Private Laboratories
- Military Blood Banks
Current and Emerging Products
- Analysis of current and emerging transfusion
- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.
- Assessment of current and emerging
technologies, and their potential applications
for the transfusion diagnostics market.
- Comprehensive lists of companies developing
or marketing new technologies and products, by test.
Worldwide Market Overview
- Estimates of facilities performing transfusion diagnostic
tests, by country.
- Test volume and sales projections by country.
- New product development
opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
The report is based on combination of primary and secondary information sources, including interviews with blood bankers, laboratory directors, and executives of leading diagnostics companies in the U.S., five major European countries, and Japan.
In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.
Contains 800 pages and 240 tables